Summary
A reversed-phase HPLC method has been developed for the urinary determination of mutagenic 2,4- and 2,6-toluendiamines. These amines are degradation products of polyurethane, a material used to cover textured silicone breast implants. FMOC-Cl was used as fluorescent derivatising agent in order to obtain a limit of detection of 15 ng/ml in urine. Pre-treatment of urine samples was by liquid/liquid extraction and urine specimens of patients after surgury were analysed.
Similar content being viewed by others
References
W. C. Hueper, J. Natl. Cancer Inst.33, 1005 (1964).
N. Ito, Y. Hiasa, Y. Konishi, M. Marugami, Cancer Res.29, 1137 (1969).
C. L. Slade, H. D. Peterson, Plast. Reconstr. Surg.70, 379 (1982).
S. C. Chan, D. C. Birdsell, C. J. Gradeen, Clin. Chem.37, 756 (1991).
M. Dalene, L. Mathiasson, S. Skarping, C. Sangö, J. F. Sandström, J. Chromatogr.435, 469 (1988).
E. H. Nieminen, L. H. Saarinen, J. T. Laakso, J. Liq. Chromatogr.6, 453 (1983).
K. Johansson, C. Rappe, W. Lindberg, M. Nygren, IARC Scientific Publication40, 243 (1981).
R. C. Snyder, W. C. Brumley, C. V. Breder, T. Fazio, J. Assoc. Off. Anal. Chem.65, 1388 (1982).
R. C. Snyder, C. V. Breder, J. Chromatogr.,236, 429 (1982).
C. J. P. Ward, D. M. Radzik, P. T. Kissinger, J. Liq. Chromatogr.8, 677 (1985).
T. Hirayama, M. Ono, K. Uchiyama, M. Nohara, S. Fukui, J. Assoc. Off. Anal. Chem.68, 746 (1985).
P. D. Unger, M. A. Friedman, J. Chromatogr.,174, 379 (1979).
C. Rosenberg, H. Savolainen, J. Chromatogr.,323, 429 (1985).
T. Brorson, G. Skarping, C. Sango, Occup. Environ. Health63, 253 (1991).
J. F. Sandström, G. Skarping, M. Dalene, J. Chromatogr.479, 135 (1989).
G. Skarping, L. Renman, B. E. F. Smith, J. Chromatogr.267, 315 (1983).
S. Einarsson, B. Josefsson, S. Lagerkvist, J. Chromatogr.282, 609 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Lorenzi, E., Massolini, G., Macchia, M. et al. HPLC determination of urinary 2,4- and 2,6-toluendiamines as potential degradation products of polyurethane breast implants. Chromatographia 41, 661–664 (1995). https://doi.org/10.1007/BF02267801
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02267801